KRAS and neoplasm: More importantly, it was shown in vivo that Nrf2 deficiency reverses the reduction in ROS due to KrasG12D and causes a significant reduction in tumor volume and tumor cell proliferation in oncogenic Kras mouse models of pancreatic and lung cancer9.